Different roles for interleukin-4 during the course of Toxoplasma gondii infection

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 897-904

  Roberts, C W ^a,b   Ferguson, D J P ^c   Jebbari, H ^a   Satoskar, A ^a   Bluethmann, H ^d   Alexander, J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b MICHAEL REESE HOSPITAL   (United States)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HOST PARASITE INTERACTION; IMMUNOCYTOCHEMISTRY; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITISM; PRIORITY JOURNAL; SPLEEN CELL; TOXOPLASMA GONDII;

EID: 0030040851     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.897-904.1996     Document Type: Article

References (58)

1. Blackwell, J. M., C. W. Roberts, and J. Alexander. 1993. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gonda: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol 15:317-324.
2. Blackwell, J. M., C. W. Roberts, T. I. A. Roach, and J. Alexander. 1994. Influence of macrophage resistance gene Lsh/Ity/Bcg (candidate Nramp) on Toxoplasma gondii infection in mice. Clin Exp. Immunol. 97:1-6
3. Bohne, W., J. Heesemann, and U. Gross. 1993. Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages Infect Immun. 61:1141-1145.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254
5. Brown, C. R., and R. McLeod. 1990 Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145:3438-3441.
6. Burke, J. M., C. W. Roberts, C. A. Hunter, M. Murray, and J. Alexander. 1994. Temporal differences in the expression of mRNA for IL-10 and IFN-γ in the brains and spleens of C57BL10 mice infected with Toxoplasma gondii. Parasite Immunol. 16:305-314.
7. Candolfi, E., C. A. Hunter, and J. S. Remington. 1994. Mitogen-and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect. Immun. 62:1995-2001
8. Candolfi, E., C. A. Hunter, and J. S. Remington. 1995. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis Infect. Immun. 63:751-756.
9. Chang, H. R., G. E. Grau, and J. C. Pechere. 1990. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology 69:33-37.
10. Chao, C. C., G. Gekker, S. Hu, and P. K. Peterson. 1994. Human microglial cell defence against Toxoplasma gondu. The role of cytokines. J. Immunol. 152:1246-1252
11. Chatelain, R., K. Varkila, and R. L. Coffman. 1992 IL-4 induces a Th2 response in Leishmania major infected mice. J. Immunol. 148:1182-1187.
12. Clark, I. A., K. A. Rockett, and W. B. Cowden. 1991. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol. Today 7:205-207
13. Coffman, R. L., and J. Carty. 1986 A T cell activity that enhances the polyclonal IgE production and its inhibition by interferon-gamma. J. Immunol. 136:949-954.
14. Cook, G. C. 1990. Toxoplasma gondii infection, a potential danger to the unborn fetus and AIDS sufferer. Q. J. Med 273:3-19.
15. Denkers, E. Y., P. Caspar, and A. Sher. 1994. Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell activity that selectively expands murine T cell receptors Vβ5-bearing CD8+ lymphocytes. J. Exp. Med. 180:985-994.
16. Dimier, I. H., and D. T. Bout. 1993. Co-operation of interleukin-1β and tumour necrosis factor-α in the activation of human umbilical vein endothelial cells to inhibit Toxoplasma gondii replication. Immunology 79:336-338.
17. Economou, J. S., W. H. McBride, R. Essener, K. Rhoades, S. Golub, E. C. Holmes, and D. L. Morton. 1989. Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo. Immunology 67:514-519.
18. Essner, R., K. Rhoades, W. H. McBride, D. L. Morton, and J. S. Economou. 1989. IL-4 downregulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142:3857-3862.
19. Frenkel, J. K., and D. W. Taylor. 1982. Toxoplasmosis in immunoglobulin μ-suppressed mice Infect. Immun. 38:360-367.
20. Gautum, S., J. M. Tebo, and T. A. Hamilton. 1992 IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages. J. Immunol. 148:1725-1730.
21. Gazzinelli, R. T., F. T. Hakim, S. Hieny, G. M. Shearer, and A. Sher. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292
22. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. J. Immunol 148:1792-1796.
23. Haque, S., I. Khan, A. Haque, and L. Kasper. 1994. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin-2 production and macrophage-mediated inhibitory effects. Infect. Immun 62:2908-2916.
24. Hanser, W. E., and V. Tsau. 1986. Acute toxoplasma infection of mice induces spleen NK cells that are cytotoxic for Toxoplasma gondii in vitro. J. Immunol. 136:313-319.
25. Hughes, H. P. A. 1988. Oxidative killing of intracellular parasites mediated by macrophages. Parasitol. Today 4:340-347.
26. Hunter, C. A., E. Candolfi, C. Subauste, C. V. Van, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16-20.
27. Hunter, C. A., M. J. Litton, J. S. Remington, and J. S. Abrams. 1994. Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. J. Infect. Dis. 170:939-945.
28. Hunter, C. A., C. W. Roberts, and J. Alexander. 1992. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur. J. Immunol 22:2317-2322
29. Hunter, C. A., C. S. Subauste, and J. S. Remington. 1994. The role of cytokines in toxoplasmosis Biotherapy 7:237-247.
30. Jackson, M. H., and W. M. Hutchison. 1989. The prevalence and source of Toxoplasma infection in the environment. Adv. Parasitol. 28:55-105
31. Johnson, L. L. 1992. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii. Infect Immun. 60:1979-1983
32. Jun, C. D., S. H. Kim, C. T. Soh, S. S. Kang, and H. T. Chung. 1993. Nitric oxide mediates the toxoplasmastatic activity of murine microghal cells in vitro. Immunol. Invest. 22:487-501.
33. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496-2505.
34. Khan, I. A., T. Matsuura, and L. H. Kasper. 1991. Interleukin-12 enhances murine survival against acute toxoplasmosis Infect. Immun. 62:1639-1642.
35. Khan, I. A., T. Matsuura, and L. H. Kasper. 1995. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol 17:185-195.
36. Kopf, M., G. L. Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (London) 362:245-247.
37. Langermans, J. A. M., M. E. B. Van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. Van Furth. 1992. IFN-γ induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol 148:568-574.
38. Luft, B. J., and J. S. Remington. 1988. Toxoplasmic encephalitis. J. Infect. Dis. 157:1-5.
39. McLeod, R., P. Eisenhauer, D. Mack, C. Brown, G. Filice, and G. Spitalny. 1989. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 142:3247-3256.
40. McLeod, R., E. Skamene, C. R. Brown, P. B. Eisenhauer, and D. G. Mack. 1989 Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AxB/BxA recombinant inbred and B10 congenic mice. J. Immunol. 143:3031-3034.
41. Modulin, R. L., and T. B. Nutman. 1993. Type 2 cytokines and negative immune regulation m human infections Curr. Opin. Immunol. 3:511 517.
42. Mosmann, T. R., J. H. Schumacher, N. E. Sireei, K. Budd, A. O'Garra, T. A. T. Fong, M. W. Bond, K. W. M. Moore, A. Sher, and D. F. Fiorentino. 1991 Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 123:209-228.
43. Parker, S. J., C. W. Roberts, and J. Alexander. 1991. CD8+ T cells arc the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondu in mice. Clin. Exp. Immunol. 84:207-212.
44. Peterson, P. K., G. Gekker, S. Hu, and C. C. Chao. 1995. Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. J Infect. Dis. 171:516-518
45. Roberts, C. W., and J. Alexander. 1992. Studies on a murine model of congenital toxoplasmosis. vertical transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology 104:19-23.
46. Roberts, C. W., J. M. Brewer, and J. Alexander. 1994. Congenital toxuplasmosis in the BALB/c mouse' prevention of vertical disease transmission and fetal death by vaccination. Vaccine 12:1389-1394
47. Roberts, C. W., S. Cruickshank, and J. Alexander. 1995. Sex determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect. Immun. 63:2549-2555.
48. Sharma, S. D., J. M. Hofflin, and J. S. Remington. 1985. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii. J. Immunol. 135:4160-4163.
49. 48a.Sher, A., et al. Personal communication.
50. Sibley, L. D., L. B. Adams, Y. Fukutomi, and J. L. Krahenbuhl. 1991. Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. J. Immunol. 147:2340-2345
51. Snapper, C. M., and W. E. Paul. 1987. Interferon and B cell stimulatory factor 1 reciprocally regulate immunoglobulin isotvpe control Science 236:944-948.
52. Suzuki, Y., F. K. Conley, and J. S. Remington. 1989 Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immunol 143:2045-2050.
53. Suzuki, Y., K. Job, M. A. Orellana, F. K. Conley, and J. S. Remington. 1991. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739.
54. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988 interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
55. Suzuki, Y., and J. S. Remington. 1988. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol. 140:3943-3946.
56. Villard, O., E. Candolfi, J. L. Despringre, F. Derouin, L. Marcellin, S. Viville, and T. Kien. 1995. Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis Parasite Immunol. 17:233-236.
57. Voller, A., D. E. Bidwell, E. Bartlett, D. G. Fleck, M. Perkins, and B. Oladehin. 1976. A microplate enzyme-immunoassay for toxoplasma antibody J. Clin. Pathol 29:150-153.
58. Williams, D. M., F. C. Grumet, and J. S. Remington. 1978. Genetic control of murine resistance to Toxoplasma gondu. Infect. Immun. 19:416-420.